Is PTIE a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

401 people get PTIE articles and Market Currents by email alert.

Get email alerts on PTIE »

HEADLINES:

FDA Painkiller Abuse Concerns Creating Opportunity For Pfizer
Cory Renauer • Mon, May 20 • 2 Comments
Pain Therapeutics to Present at the Bank of America Merrill Lynch 2013 Health Care Conference

GlobeNewswire (May 13, 2013)
Pain Therapeutics Files Form 8-K Regarding Correspondence From Pfizer, Inc.

GlobeNewswire (May 10, 2013)
Pfizer's Efforts Boost Pain Therapeutics And Durect Corp.
Bob's Stocks • Thu, May 2 • 9 Comments
Why Did Pain Therapeutics Increase Over 25%?
C.R. Jackson • Thu, May 2 • 35 Comments
Pain Therapeutics Reports Q1 2013 Financial Results

GlobeNewswire (Apr 24, 2013)
3 Companies Aiming For The $1.2B Opioid Addiction Market
Healthcare Specialist • Sun, Apr 7 • 29 Comments
Durect Corporation And Pain Therapeutics Big Gainers For 2013?
Bob's Stocks • Thu, Mar 21 • 7 Comments
All You Need To Know About Remoxy
Basileus • Mon, Feb 18 • 8 Comments
Pain Therapeutics Announces New Board Member

GlobeNewswire (Feb 12, 2013)
Pain Therapeutics Reports 2012 Financial Results

GlobeNewswire (Feb 6, 2013)
Imminent Catalysts Should Keep Investor Interest Alive For These Pharmaceuticals - Part II
Chemistfrog • Mon, Feb 4 • 9 Comments
Madison Street Partners Is The Little Fund That Could
Marshall Hargrave • Sun, Jan 27
Is Zogenix A Buy After FDA Panel Says 'No' To Zohydro?
C.R. Jackson • Fri, Dec 14, 2012 • 15 Comments
Pain Therapeutics Declares Special One-Time Cash Distribution to Shareholders

GlobeNewswire (Dec 7, 2012)
Pain Therapeutics to Present at the Credit Suisse 2012 Healthcare Conference

GlobeNewswire (Nov 9, 2012)
Pain Therapeutics Reports Q3 2012 Financial Results

GlobeNewswire (Nov 8, 2012)
Pain Therapeutics - Another Oxycodone Remix
Suresh Gupta • Tue, Oct 23, 2012 • 3 Comments
3 Best Biotech Stocks For This Week (Part V)
Jorge Aura • Mon, Oct 8, 2012 • 2 Comments
5 Low-Debt Biotech Stocks Forecasted For Growth
ZetaKap • Sat, Sep 22, 2012

To learn more about Seeking Alpha Pro, click here.

Why Did Pain Therapeutics Increase Over 25%?
C.R. Jackson • Thu, May 2 • 35 Comments
Pain Therapeutics - Another Oxycodone Remix
Suresh Gupta • Tue, Oct 23, 2012 • 3 Comments
Pfizer Guidance Suggests Tremendous Potential for Pain Therapeutics
SeekingValue • Wed, Aug 17, 2011 • 4 Comments
Pain Therapeutics' Opium for the Masses
Jim Van Meerten • Thu, Mar 24, 2011 • 3 Comments
Pain Therapeutics: Optimistic Indicators, Large Upside Potential
SeekingValue • Tue, Feb 8, 2011 • 17 Comments
Pain Therapeutics: No Pain, No Profit Gain
Mike Havrilla • Thu, Nov 29, 2007
Pain Theraputics: Is It Worth The Risk?
H.S. Ayoub • Tue, Nov 21, 2006
The Long Case for Pain Therapeutics
Top Textrader • Thu, Oct 19, 2006

FDA Painkiller Abuse Concerns Creating Opportunity For Pfizer
Cory Renauer • Mon, May 20 • 2 Comments
Pfizer's Efforts Boost Pain Therapeutics And Durect Corp.
Bob's Stocks • Thu, May 2 • 9 Comments
3 Companies Aiming For The $1.2B Opioid Addiction Market
Healthcare Specialist • Sun, Apr 7 • 29 Comments
Durect Corporation And Pain Therapeutics Big Gainers For 2013?
Bob's Stocks • Thu, Mar 21 • 7 Comments
All You Need To Know About Remoxy
Basileus • Mon, Feb 18 • 8 Comments
Imminent Catalysts Should Keep Investor Interest Alive For These Pharmaceuticals - Part II
Chemistfrog • Mon, Feb 4 • 9 Comments
Madison Street Partners Is The Little Fund That Could
Marshall Hargrave • Sun, Jan 27
Is Zogenix A Buy After FDA Panel Says 'No' To Zohydro?
C.R. Jackson • Fri, Dec 14, 2012 • 15 Comments
3 Best Biotech Stocks For This Week (Part V)
Jorge Aura • Mon, Oct 8, 2012 • 2 Comments
5 Low-Debt Biotech Stocks Forecasted For Growth
ZetaKap • Sat, Sep 22, 2012
Buy Durect As Visibility On Remoxy Improves
Jason Napodano • Tue, Sep 11, 2012 • 5 Comments
Durect Corporation - A Unique & Undervalued Biopharma Development Company
Kyle Walker • Thu, Aug 30, 2012 • 9 Comments
5 High-Growth Biotechnology Stocks That Analysts Strongly Favor
ZetaKap • Sat, Aug 25, 2012 • 21 Comments
Bear Raids And Tree Shaking In Biotechnology And Drugs
Joe Springer • Tue, Aug 7, 2012 • 13 Comments
7 Highly Liquid Stocks Under $5 On Winning Streaks
Kapitall • Wed, Jul 4, 2012 • 3 Comments
Pain Management Stocks: Will This Painful Downturn End Soon?
Simon Monger • Thu, Dec 1, 2011 • 4 Comments
Acura Pharma Doesn't Show Any Signs Of Slowing Down
Andrew Garn • Sun, Oct 16, 2011 • 7 Comments
Major Corporate And Institutional Insider Filings Last Week
GuruFundPicks • Wed, Oct 12, 2011 • 1 Comment
4 Big Losers From Last Week
Alex Shadunsky • Mon, Jul 4, 2011 • 2 Comments
Stocks Seeing Selling Pressure This Week
Alex Shadunsky • Thu, Jun 30, 2011 • 1 Comment

There are no Transcripts on PTIE.

Pain Therapeutics to Present at the Bank of America Merrill Lynch 2013 Health Care Conference

GlobeNewswire (May 13, 2013)
Movers & Shakers: Friday’s movers: Tesla, Groupon notch weekly gains

at MarketWatch.com (May 10, 2013)
Pain Therapeutics Files Form 8-K Regarding Correspondence From Pfizer, Inc.

GlobeNewswire (May 10, 2013)
Pain Therapeutics Reports Q1 2013 Financial Results

GlobeNewswire (Apr 24, 2013)
Pain Therapeutics Announces New Board Member

GlobeNewswire (Feb 12, 2013)
Pain Therapeutics Reports 2012 Financial Results

GlobeNewswire (Feb 6, 2013)
Pain Therapeutics Declares Special One-Time Cash Distribution to Shareholders

GlobeNewswire (Dec 7, 2012)
Pain Therapeutics to Present at the Credit Suisse 2012 Healthcare Conference

GlobeNewswire (Nov 9, 2012)
Pain Therapeutics Reports Q3 2012 Financial Results

GlobeNewswire (Nov 8, 2012)
Pain Therapeutics Reports Q2 2012 Financial Results

GlobeNewswire (Aug 2, 2012)
Pain Therapeutics Publishes Novel Approach to Treat Alzheimer's Disease

GlobeNewswire (Jul 18, 2012)
Pain Therapeutics to Present at Jefferies Healthcare Conference

GlobeNewswire (Jun 5, 2012)
Pain Therapeutics Reports Q1 2012 Financial Results

GlobeNewswire (May 8, 2012)
Four U.S. Patents Issued for REMOXY

GlobeNewswire (May 3, 2012)
Movers & Shakers: Monday’s biggest gaining and declining stocks

at MarketWatch.com (Jun 27, 2011)
Biotech Stocks: Icagen rallies as drug stocks head north

at MarketWatch.com (Jun 27, 2011)
Dow, S&P End Lower for 7 Out of 8 Weeks

at CNBC.com (Jun 24, 2011)
Movers & Shakers: Friday’s biggest gaining and declining stocks

at MarketWatch.com (Jun 24, 2011)
Stocks Set to End Lower Amid Euro Debt Fears

at CNBC.com (Jun 24, 2011)
Stocks Slide Amid New Euro Zone Jitters

at CNBC.com (Jun 24, 2011)

PTIE vs. ETF Alternatives

Company Description

Currently, there's no company description for PTIE.

Sector: Healthcare

Industry: Drug Manufacturers - Other

Country: United States

All
| Earnings
| Dividends
| M&A
| On the move

Friday, May 10, 12:52 PM Midday top 10 gainers: UNIS +58%. DRAM +57%. VRML +26%. SREV +22%. MCP +20%. UBNT +18%. RH +18%. WCRX +17%. CSIQ +16%. SQNM +16%.
Midday top 10 losers: PTIE -48%. DRRX -41%. IFMI -34%. AFFY -26%. SRT -23%. LPDX -22%. OPTR -17%. REFR -16%. PANL -16%. TRMD -15%. Comment! [On the Move]
Friday, May 10, 9:10 AM Premarket gainers: PGNX +26%. UNIS +21%. UBNT +19%. SQNM +11%. MCP +11%. XIN +7%. NBG +6%. NTE +5%. MT +5%.
Losers: PTIE -48%. IFMI -36%. AFFY -18%. SNTS -7%. OPTR -7%. DDD -6%. MDRX -6%. LFVN -5%. Comment! [On the Move]
Friday, May 10, 8:12 AM Pain Therapeutics (PTIE) craters 45.5% in premarket trading after Pfizer (PFE) says it is "considering its options" on Remoxy and may not respond to the FDA's complete response letter anytime in the next two years. PTIE sub-licensed Remoxy's commercialization rights to PFE subsidiary King Pharma (I, II). Comment! [Healthcare, On the Move]
Tuesday, April 30, 12:46 PM Midday top 10 gainers: TTHI +45%. PTIE +26%. DRRX +26%. MTOR +23%. MGAM +20%. OIS +16%. GIB +14%. HGSH +15%. ARWR +13%. TXRH +13%.
Midday top 10 losers: DCTH -44%. AVEO -26%. NUAN -18%. AOSL -18%. PBI -16%. AEIS -13%. MSTR -10%. ANV -10%. ELTK -10%. SYN -10%. Comment! [On the Move]
Tuesday, April 30, 11:41 AM Pain Therapeutics (PTIE +19%) and Durect (DRRX +25.5%) both soar on the back of positive comments out of Pfizer's (PFE) conference call about Remoxy, an oxycodone capsule the pair have been developing. PTIE sub-licensed Remoxy's commercialization rights to King Pharmaceuticals, which is a subsidiary of PFE, and the pharma-giant noted in its call that it's had a productive meeting with the FDA last month regarding the drug. (PFE Conference Call Webcast) 1 Comment [Healthcare, On the Move]
Wednesday, April 24, 9:28 AM Pain Therapeutics (PTIE): Q1 EPS of -$0.01 in-line. Revenue of $1.96M misses by $0.84M. (PR) Comment! [Earnings, Breaking News]
Wednesday, April 17, 10:56 AM Shares of Pain Therapeutics (PTIE +1.4%) benefit from the FDA's "public health priority" call on abuse-deterrent opioid analgesics. PTIE is developing Remoxy, an abuse-resistant form of oxycodone in conjunction with Pfizer (PFE). Other names moving on the news: ACUR +70% and ENDP +3.2%. Comment! [Healthcare, On the Move]
Friday, April 12, 5:53 PM After-hours top gainers, as of 5:15 p.m.: PLCM +4%. WLK +4%. IM +4%. ANV +4%. RES +4%.
After-hours top losers: USLV -4%. PTIE -3%. HOLX -3%. ARP -2%. RSH -2%. Comment! [On the Move]
Wednesday, February 6, 9:45 AM Pain Therapeutics (PTIE): Q4 loss per share of $0.04 misses by $0.02. Revenues of $2.47M (-10.2% Y/Y) misses by $0.32M. Shares -2.4%. (PR) Comment! [Earnings, Healthcare]
Thursday, January 10, 12:45 PM Midday top 10 gainers: UCBA +48%. NOK +19%. VOXX +17%. NEWL +16%. FSCI +16%. MY +15%. HAST +15%. HGG +13%. SVU +12%. PTIE +11%.
Midday top 10 Losers: MCP -21%. GIG -21%. DRWI -20%. UNXL -14%. PRXI -8%. QRM -8%. ASNA -8%. THLD -8%. SSRI -8%. PRGN -7%. 1 Comment [On the Move]
Thursday, December 13, 2012, 12:45 PM Midday top 10 gainers: ONCY +51%. TELK +23%. PRGN +21%. GBR +17%. SDBT +16%. SAM +15%. BBY +15%. CLWR +14%. ZAGG +14%. TROV +13%.
Midday top 10 Losers: RIGL -35%. EVI -31%. HRG -26%. PTIE -19%. CBMX -18%. OSN -15%. MEIP -13%. DQ -12%. CSUN -12%. ALLT -11%. Comment! [On the Move]
Thursday, November 1, 2012, 12:45 PM Midday top 10 gainers: HGSH +78%. WMCO +41%. KSWS +35%. CHC +32%. REDF +26%. GTIV +23%. WNC +22%. IMH +20%. JDAS +17%. NEWP +16%. Midday top 10 Losers: CMVT -48%. DRRX -39%. PTIE -30%. ABMD -30%. FARO -18%. AAWW -17%. FBN -16%. GBX -14%. ZUMZ -14%. EONC -14%. Comment!
Friday, August 17, 2012, 12:22 PM Pain Therapeutics (PTIE +1.3%) moves up after being initiated with a Buy at C.K. Cooper. The firm says it wants to stay ahead of an potentially positive news on Remoxy, its extended release capsules of oxycodone being developed with Pfizer (PFE -1.2%). The FDA rejected the drug in June, but Cooper believes the stock will move higher once PFE clarifies its plans for resubmission. Comment! [Healthcare, On the Move]
Monday, June 27, 2011, 3:54 PM Pain Therapeutics (PTIE -24.7%) is Nasdaq's leading loser for the second straight session, adding to Friday's 40%-plus drop after the FDA rejected a new drug application for Remoxy, its extended release capsules of oxycodone developed with Pfizer (PFE +0.4%). Durect (DRRX -8.5%), whose technology was used to develop the drug, also adds to losses. Comment! [Healthcare, On the Move]
Monday, June 27, 2011, 9:10 AM Premarket gainers: CNU +32%. LDK +6%. ACUR +6%. ZLCS +5%. SGMO +4%. ALU +3%. SINA +3%. ERIC +3%. ASML +3%.
Losers: PTIE -29%. DRRX -16%. XCO -4%. CTIC -3%. RDN -3%. Comment! [On the Move]
Friday, June 24, 2011, 11:11 AM Durect (DRRX -28%) is another casualty of the FDA's rejection of Remoxy. Its technology - designed to discourage common methods of tampering - was used to develop the drug. PTIE -37%, PFE -1.5%. Comment! [Healthcare, On the Move]

Nefas
Stocks i am watching next week $ZAGG, $MNKD, $HLF, $BBRY, $NOK, $MUX, $NBG, $PTIE, $PFE, $MTG..any suggestions ideas on my watchlist?
May 11, 10:02 AM
Reply (4)

• !Report Abuse
View all 4 replies
Seacap: I'm going to jump all over BBRY past 16.60
May 13, 12:24 AM
• !Report Abuse
Bigisbetter: DDD
May 14, 12:35 PM
• !Report Abuse
Add a reply...

140 characters

Nefas
Am i to latte to the whole Bio/Pharma stuff with $HLF, $MNKD $PFE, $PTIE...i feel like i might be....
May 10, 5:22 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

1980XLS
$PTIE Lots of Pain (no position)
May 10, 11:09 AM
Reply (6)

• !Report Abuse
View all 6 replies
IALF: if they drop it I'd play the dead cat. Seeing as it has been rejected twice by the FDA I'm not hopeful.
May 10, 4:18 PM
• !Report Abuse
Nefas: So i literally have to check $PFE if i wanna go into $PTIE thx for the heads up :)
May 10, 5:22 PM
• !Report Abuse
Add a reply...

140 characters

Jbgoose
$PTIE can legislation mandate tamper proof in generic tier 1/2 formulary? Shouldn't they? Will they? Happy Int'l Jazz Day.
Apr 30, 11:49 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Red Acre Investments
Take our poll about $PFE and Remoxy $DRRX and $PTIE investors too! http://bit.ly/14k2VHo
Apr 24, 12:39 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Red Acre Investments
Binary Event Watch April 2013 - Part II http://bit.ly/114CVMl ... $RPTP $AVEO $DCTH $VVUS $SRPT $PFE $DRRX $PTIE $TTNP $XNPT $EXAS
Apr 12, 12:25 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Red Acre Investments
April binary event watch pt2 $PFE $RPTP $TTNP $AVEO $DCTH $PFE $SRPT $VVUS $AGN $DRRX $PTIE $XNPT $EXAS get it free: http://bit.ly/10SbDco
Apr 11, 7:03 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Rancodemayor
$PTIE is popping for no apparent reason. Stock is up 10%.
Mar 7, 12:17 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ZetaKap
5 Low-Debt Biotech Stocks Forecasted For Growth http://bit.ly/SbHrRH $ACAD $BSTC $DRTX $MACK $PTIE @ZetaKap
9/22/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ZetaKap
5 High-Growth Biotechnology Stocks That Analysts Strongly Favor http://bit.ly/QcrgYX $CERS $CTIC $MACK $PTIE $ZLCS @ZetaKap
8/25/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

LATEST REPLIES

Nefas
Stocks i am watching next week $ZAGG, $MNKD, $HLF, $BBRY, $NOK, $MUX, $NBG, $PTIE, $PFE, $MTG..any suggestions ideas on my watchlist?
May 11, 10:02 AM
Reply (4)

• !Report Abuse
View all 4 replies
Seacap: I'm going to jump all over BBRY past 16.60
May 13, 12:24 AM
• !Report Abuse
Bigisbetter: DDD
May 14, 12:35 PM
• !Report Abuse
Add a reply...

140 characters

1980XLS
$PTIE Lots of Pain (no position)
May 10, 11:09 AM
Reply (6)

• !Report Abuse
View all 6 replies
IALF: if they drop it I'd play the dead cat. Seeing as it has been rejected twice by the FDA I'm not hopeful.
May 10, 4:18 PM
• !Report Abuse
Nefas: So i literally have to check $PFE if i wanna go into $PTIE thx for the heads up :)
May 10, 5:22 PM
• !Report Abuse
Add a reply...

140 characters

PTIE Pain Therapeutics

PTIE

Pain Therapeutics